David
Santamaría Velilla
German Cancer Research Center
Heidelberg, AlemaniaGerman Cancer Research Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
Nature Medicine, Vol. 22, Núm. 3, pp. 270-277